Literature DB >> 6239307

Depressor and natriuretic activities of several atrial peptides.

J Tang, R J Webber, D Chang, J K Chang, J Kiang, E T Wei.   

Abstract

Mammalian atria contain peptides that have depressor and natriuretic activities. Four peptides, atriopeptin I to III (AP I to III) and alpha-human atrial natriuretic factor (alpha-hANP), were synthesized and assayed in the urethane-anesthetized rat for cardiovascular changes and natriuretic activities. All four peptides produced depressor responses and natriuresis. The relative activities were: alpha-hANP = AP III greater than AP II greater than AP I. The disappearance of iodinated AP III from plasma was rapid, with an estimated half-life of 2.5 min. Atriopeptin III was degraded by tissue homogenates, the relative activities being: kidney greater than liver greater than lung greater than plasma greater than heart. The HPLC profile of AP III suggested that smaller peptide fragments were formed after incubation with kidney homogenates. The degradation of AP III was inhibited by bestatin, an aminopeptidase inhibitor, and SQ 20881, a carboxypeptidase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239307     DOI: 10.1016/0167-0115(84)90007-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

Review 1.  The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.

Authors:  A M Richards
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

2.  Monitoring effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) on left ventricular function in patients with essential hypertension with a cardiac probe.

Authors:  X J Liu; Y Z Liu; Z X He; B G Zhou; L S Liu; H N Wagner
Journal:  Eur J Nucl Med       Date:  1987

3.  Characterization and distribution of receptors for the atrial natriuretic peptides in mammalian brain.

Authors:  R Quirion; M Dalpé; T V Dam
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli.

Authors:  B J Ballermann; R L Hoover; M J Karnovsky; B M Brenner
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

5.  Haemodynamic and renal tubular responses to low-dose infusion or bolus injection of the peptide ANF in anaesthetized rats.

Authors:  P J Harris; S L Skinner; J Zhuo
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

6.  Rapid receptor-mediated catabolism of 125I-atrial natriuretic factor by vascular endothelial cells.

Authors:  G R Johnson; L Arik; B J Pitts; C J Foster
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

7.  Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.

Authors:  H Berglund; O Nyquist; B Beermann; M Jensen-Urstad; E Theodorsson
Journal:  Br Heart J       Date:  1994-12

8.  Blood levels and renal effects of atrial natriuretic peptide in normal man.

Authors:  P Weidmann; L Hasler; M P Gnädinger; R E Lang; D E Uehlinger; S Shaw; W Rascher; F C Reubi
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 9.  Atrial natriuretic peptide in the central nervous system of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

10.  Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion.

Authors:  R J Schiebinger; M Z Baker; J Linden
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.